 Medgadget.com | Medtronic gets FDA approval for heart-failure device Minneapolis / St. Paul Business Journal (blog) Medtronic Inc. has won regulatory approval to sell its Viva cardiac device, which targets patients suffering from heart failure, the company announced Monday. Patients treated with the Viva resynchronization device experienced 21 percent fewer ... Medtronic Announces FDA Approval of New Portfolio of Next - Gen Cardiac ... Medtronic's Viva Wins US Approval to Resynchronize Heart (2) Medtronic's new device sparks war of words with Boston Scientific |
